Shots: This is the first launch of a biosimilar to Humira in Japan. Mylan EPD will lead the commercialization of the biosimilar The launch is a testament to the power […]readmore
Tags : Fujifilm Kyowa Kirin
1. LEO Reports the US FDA’s Acceptance of BLA for Tralokinumab to Treat Adults with Moderate to Severe Atopic Dermatitis Published Date: Jul 10, 2020 | Tags: LEO, Reports, US, […]readmore
Shots: The US FDA has approved Hulio (adalimumab-fkjp), a biosimilar to AbbVie’s Humira (adalimumab) to treat RA, JIA (in patients aged ≥4yrs.), PsA, AS, adult CD, UC, and PsO, in […]readmore